Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO >

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	101.44

NSE Code	SUNPHARMA
Dividend Yield %	0.96
Market Cap	3995492.56

P/E	93.30
EPS	17.85
Face Value	1


	BSE		NSE

04-Jun-2025

Last Price	1665.25
Net Change	-2.4
% Change	-0.14%
Prev.Close	1667.65
Open	1648.20
High	1669.25
Low	1648.20
Volume	80805

Last Price	1664.90
Net Change	-2.6
% Change	-0.16%
Prev.Close	1667.50
Open	1656.00
High	1669.00
Low	1649.00
Volume	1700482

Value	134076260
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1669.25
52-Week High	1960.20
52-Week Low	1434.00

Value	2825880489.2
Best Buy	1664.90
Best Sell	0.00
Best Quantity	87
Sell Quantity	0
Today's Range	1669.00
52-Week High	1960.35
52-Week Low	1432.00

Open Price	1650.50
High Price	1676.80
Low Price	1650.50
Last Price	1671.50
Prev Close	1676.80
Change	-5.30
% Change	-0.32 %

Average Price	1669.95
Underlying Value	1664.90
Number of contracts traded	5043
Turnover in Rs. Lakhs	29475
Open Interest	16882950.00
Change in O I	8750.00
% Change in O I	0.05 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	87
Price	1664.90

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	700
Price	1670

Quantity	350
Price	1671.1

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

1050 %

06-Feb-25

Company News

26-05-2025

Sun Pharmaceutical Indust...

23-05-2025

Sun Pharmaceutical Indust...

24-04-2025

Sun Pharmaceutical Indust...

14-04-2025

Sun Pharmaceutical Indust...

11-04-2025

US court lifts restrictio...

11-04-2025

Sun Pharma surges after U...

07-04-2025

Sun Pharma launches Fexup...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.